These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 18349265

  • 41. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?
    Podgorski I, Linebaugh BE, Sloane BF.
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):701-3. PubMed ID: 17635127
    [Abstract] [Full Text] [Related]

  • 42. [Physiopathology, diagnosis and management of bone metastases from prostate cancer].
    Lebret T, Méjean A.
    Prog Urol; 2008 Nov; 18 Suppl 7():S349-56. PubMed ID: 19070815
    [Abstract] [Full Text] [Related]

  • 43. Clinical features of metastatic bone disease and risk of skeletal morbidity.
    Coleman RE.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708
    [Abstract] [Full Text] [Related]

  • 44. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 45. Heparanase promotes bone destruction and invasiveness in prostate cancer.
    Zhou Y, Song B, Qin WJ, Zhang G, Zhang R, Luan Q, Pan TJ, Yang AG, Wang H.
    Cancer Lett; 2008 Sep 18; 268(2):252-9. PubMed ID: 18487013
    [Abstract] [Full Text] [Related]

  • 46. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
    Power CA, Pwint H, Chan J, Cho J, Yu Y, Walsh W, Russell PJ.
    Prostate; 2009 Nov 01; 69(15):1613-23. PubMed ID: 19585491
    [Abstract] [Full Text] [Related]

  • 47. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L, Costantini E, Zucchi A, Mearini E, Bini V, Cottini E, Porena M.
    Urol Int; 2008 Nov 01; 80(2):134-40. PubMed ID: 18362481
    [Abstract] [Full Text] [Related]

  • 48. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers.
    Kehinde EO, Maghrebi MA, Anim JT.
    Can J Urol; 2008 Apr 01; 15(2):3967-74. PubMed ID: 18405443
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Mechanisms of bone metastasis in prostate cancer: clinical implications.
    Msaouel P, Pissimissis N, Halapas A, Koutsilieris M.
    Best Pract Res Clin Endocrinol Metab; 2008 Apr 01; 22(2):341-55. PubMed ID: 18471791
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Skeletal implications of prostate cancer.
    Bagi CM.
    J Musculoskelet Neuronal Interact; 2003 Jun 01; 3(2):112-7. PubMed ID: 15758351
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Risk factors of hyperparathyroidism in advanced stages of chronic kidney disease.
    El Kossi M, Rana A, El Nahas M.
    Saudi J Kidney Dis Transpl; 2009 Jul 01; 20(4):623-7. PubMed ID: 19587504
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.
    Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA.
    J Clin Oncol; 2009 Aug 01; 27(22):3605-10. PubMed ID: 19546403
    [Abstract] [Full Text] [Related]

  • 58. Metastatic adenocarcinoma of prostate in a healing sternotomy site.
    Adams G, Mitchell A, Ravichandran R, Beer TM, Garzotto M.
    Urology; 2006 Jul 01; 68(1):204.e13-5. PubMed ID: 16808964
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Roles for the calcium sensing receptor in primary and metastatic cancer.
    Manning AT, O'Brien N, Kerin MJ.
    Eur J Surg Oncol; 2006 Sep 01; 32(7):693-7. PubMed ID: 16765016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.